Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that Richard Rubino, Chief Financial Officer, will present at the Cantor Fitzgerald 2018 Global Healthcare Conference on Tuesday, October 2, 2018 at 2:15 p.m.
September 25, 2018
· 2 min read